DoubleLine ETF Adviser LP

Mutual Fund

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1959989 Tampa, FL

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,464,856

+$21,193 QoQ

Shares Held

2,949

-8.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.60%

of 13F equity value

Holder Rank

#753

of 1,735 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DoubleLine ETF Adviser LP holds $2,688,568 across 4 Biotechnology names. VRTX ranks #1 (54.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,949	$1,464,856
2	REGN	Regeneron Pharmaceuticals, Inc.	1,209	$753,859
3	MRNA	Moderna, Inc.	3,760	$263,312
4	INCY	Incyte Corp	1,822	$206,541

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,464,856	2,949	-8.8%	Shares	Sole	2026-08-14
2026-03-31	$1,443,663	3,233	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.